CALB (03931) acquires 8.3155% equity interest in a Wuhan company, increasing its shareholding to 59.3155%.
Zhongchuang Xinhang (03931) announced that on December 23, 2025, the company successfully bid for the equity subject matter submitted for sale by the seller at the open bidding held at the North Exchange. Therefore, on December 24, 2025, the company entered into a property transaction contract with the seller, in which the company agreed to purchase and the seller agreed to sell the equity subject matter for a price of 660 million RMB. The company has received the "Certificate of Enterprise State-owned Assets Transaction" issued by the North Exchange on December 24, 2025 regarding the acquisition.
CALB(03931) announced that on December 23, 2025, the company successfully bid for the target equity presented for sale by the auction seller at the auction held at the Northern Stock Exchange. Therefore, on December 24, 2025, the company entered into a property transaction contract with the seller, agreeing to purchase the target equity for RMB 660 million. The company has received a "Enterprise State-owned Assets Trading Certificate" from the Northern Stock Exchange on December 24, 2025 for the acquisition.
As of the date of this announcement, the company and the seller respectively held 51% and 49% of the target company's equity. After the bidding and acquisition are completed, the company's equity in the target company will increase from 51% to 59.3155%, and the target company will continue to be a non-wholly-owned subsidiary of the company.
Since its establishment, the Wuhan company has efficiently and quickly completed the construction and operation of production lines, with stable revenue growth and good profitability, and controllable asset-liability ratio. Based on the positive outlook for the development of the Wuhan company, the company participated in the open bidding, and the completion of this acquisition will further increase the company's ownership in the Wuhan company.
Related Articles

MEDBOT-B(02252): The electronic bronchoscope surgical navigation system has obtained registration approval from the National Medical Products Administration.

US Stock Market Move | Storage concept stocks pushing up Micron Technology, Inc. (MU.US) stock price to a new all-time high.

CH FRONTIER TEC (01661) plans to sell media content production and distribution business for 8 million Hong Kong dollars.
MEDBOT-B(02252): The electronic bronchoscope surgical navigation system has obtained registration approval from the National Medical Products Administration.

US Stock Market Move | Storage concept stocks pushing up Micron Technology, Inc. (MU.US) stock price to a new all-time high.

CH FRONTIER TEC (01661) plans to sell media content production and distribution business for 8 million Hong Kong dollars.

RECOMMEND





